Cargando…

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana

BACKGROUND: Hepatitis B surface antigen (HBsAg)–negative but hepatitis B virus (HBV) DNA-positive infection—known as occult hepatitis B infection (OBI)—occurs in 1% to >15% of HIV-positive individuals in the United States and South Africa, respectively. However, there are no data on OBI from Bots...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryan, Kathleen, Anderson, Motswedi, Gyurova, Ivayla, Ambroggio, Lilliam, Moyo, Sikhulile, Sebunya, Teresa, Makhema, Joseph, Marlink, Richard, Essex, Max, Musonda, Rosemary, Gaseitsiwe, Simani, Blackard, Jason T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641381/ https://www.ncbi.nlm.nih.gov/pubmed/29062862 http://dx.doi.org/10.1093/ofid/ofx195

Ejemplares similares

Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2016)

Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2014)

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana
por: N’Guessan, Kombo F, et al.
Publicado: (2017)

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm
por: Anderson, Motswedi, et al.
Publicado: (2018)

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2015)

Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana
por: Phinius, Bonolo Bonita, et al.
Publicado: (2020)

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana
por: Mbangiwa, Tshepiso, et al.
Publicado: (2018)

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2018)

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
por: Phinius, Bonolo B, et al.
Publicado: (2023)

Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study
por: Bhebhe, Lynnette, et al.
Publicado: (2019)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2020)

Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana
por: Baruti, Kabo, et al.
Publicado: (2020)

Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana
por: Maruapula, Dorcas, et al.
Publicado: (2021)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2023)

Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2016)

Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations With 24-Month Growth and Neurodevelopment
por: Moraka, Natasha O, et al.
Publicado: (2020)

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana
por: Choga, Wonderful Tatenda, et al.
Publicado: (2020)

Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana
por: Ragonnet-Cronin, Manon, et al.
Publicado: (2021)

Youth and healthcare workers’ perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana
por: Nambusi, Kyegombe, et al.
Publicado: (2023)

The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana
por: Campa, Adriana, et al.
Publicado: (2017)

Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana
por: Bhebhe, Lynnette, et al.
Publicado: (2022)

A1 Pairwise diversity and tMRCA as potential markers of HIV infection recency
por: Moyo, Sikhulile, et al.
Publicado: (2018)

Pairwise diversity and tMRCA as potential markers for HIV infection recency
por: Moyo, Sikhulile, et al.
Publicado: (2017)

2529. Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations with 24-Month Growth and Neurodevelopment
por: Moraka, Natasha Onalenna, et al.
Publicado: (2019)

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay
por: Rantshabeng, Patricia, et al.
Publicado: (2019)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
por: Seatla, Kaelo K., et al.
Publicado: (2021)

High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana
por: Baruti, Kabo, et al.
Publicado: (2023)

Immunohaematological reference values for HIV-negative healthy adults in Botswana
por: Mine, Madisa, et al.
Publicado: (2011)

Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages
por: Novitsky, Vlad, et al.
Publicado: (2016)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

HIV-1 drug mutations in children from northern Tanzania
por: Shao, Elichilia R., et al.
Publicado: (2014)

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2022)

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
por: Maseng, Monkgomotsi J, et al.
Publicado: (2021)

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

No Difference in Antibody Responses to Tetanus Vaccine Among HIV-Exposed and -Unexposed Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_luss2q0bkl458c2cp36f5kn0p5